SCHEMBL3748443

SCHEMBL3748443

CC(C)CC(CN)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
PDE2A O00408 2/20 0.41
TAAR1 Q96RJ0 1/20 0.40
PNMT P11086 1/20 0.37
CACNA1C Q13936 2/20 0.36
CACNA1H O95180 1/20 0.36
CACNA1B Q00975 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
MAOB P27338 1/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
KCNK2 O95069 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11078290 0.85 TAAR1 (0.48) PDE2ATAAR1PNMTCACNA1CMAOB
SCHEMBL5699189 0.84 TAAR1 (0.39) TAAR1CACNA1C
SCHEMBL28189791 0.79 PSEN1 (0.47) ALDH1A1PSEN1PSEN2APH1BNCSTN
SCHEMBL3610919 0.78 ALDH1A1 (0.49) ALDH1A1PSEN1PSEN2APH1BNCSTN
SCHEMBL11082091 0.77 TAAR1 (0.39) ALDH1A1PDE2ATAAR1CACNA1CSLC6A2
SCHEMBL3669222 0.77 ALDH1A1 (0.51) ALDH1A1PSEN1PSEN2APH1BNCSTN
SCHEMBL3647917 0.77 ACHE (0.39) TAAR1MAOB
SCHEMBL792982 0.77 TAAR1 (0.54) ALDH1A1PDE2ATAAR1PNMTCACNA1C
SCHEMBL3642655 0.76 GABBR2 (0.53) SLC6A2SLC6A4SLC6A3
SCHEMBL21610467 0.76 GABBR2 (0.53) SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120190680-A1 Heteroaryl Amide Analogues H. LUNDBECK A/S (DK) 2012-07-26 US claimed
WO-2009108551-A2 HETEROARYL AMIDE ANALOGUES H. LUNDBECK A/S (DK) 2009-09-03 WO claimed
US-9133204-B2 5-membered heterocyclic amides and related compounds H. LUNDBECK A/S (DK) 2015-09-15 US disclosed
EP-2178865-B1 5-MEMBERED HETEROCYCLIC AMIDES AND RELATED COMPOUNDS LUNDBECK H AS (DK) 2015-08-19 EP disclosed
CN-104844578-A 5-MEMBERED HETEROCYCLIC AMIDES AND RELATED COMPOUNDS NEUROGEN CORP 2015-08-19 CN disclosed
CN-101711245-B 5-membered heterocyclic amides and related compounds LUNDBECK & CO AS H 2015-03-25 CN disclosed
US-20150005293-A1 5-Membered Heterocyclic Amides And Related Compounds MINDIMMUNE THERAPEUTICS, INC. 2015-01-01 US disclosed
US-20120190680-A1 Heteroaryl Amide Analogues H. LUNDBECK A/S (DK) 2012-07-26 US disclosed
US-20100292236-A1 5-Membered Heterocyclic Amides And Related Compounds H. LUNDBECK A/S (DK) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005293-A1 5-Membered Heterocyclic Amides And Related Compounds GPR35, HCAR2, HCAR1 ALDH1A1 875/4885PSEN1 3698/4885PSEN2 3663/4885
US-20120190680-A1 Heteroaryl Amide Analogues P2RX3, P2RX2, ADORA2A ALDH1A1 1615/4885PSEN1 2947/4885PSEN2 2207/4885
US-20100292236-A1 5-Membered Heterocyclic Amides And Related Compounds GPR35, HCAR2, HCAR1 ALDH1A1 875/4885PSEN1 3698/4885PSEN2 3663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.